Oncotelic Therapeutics, Inc. (OTLC)
0.0388
0.00 (0.00%)
USD |
OTCM |
May 07, 11:36
Oncotelic Therapeutics SG&A Expense (TTM) : 3.182M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| Johnson & Johnson | 24.60B |
| Supernus Pharmaceuticals, Inc. | 395.62M |
| Sarepta Therapeutics, Inc. | 491.72M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |